New drug hope for sickle cell: panobinostat trial launches
Disease control
Recruiting now
This early-phase study tests the safety of a drug called panobinostat in 18 adults with sickle cell disease. The drug may boost fetal hemoglobin and reduce inflammation, which could help manage the disease. Participants must be 18 or older, have a confirmed diagnosis, and have no…
Phase: PHASE1 • Sponsor: Abdullah Kutlar • Aim: Disease control
Last updated May 03, 2026 22:06 UTC